Literature DB >> 33578855

Neuroblastoma Invasion Strategies Are Regulated by the Extracellular Matrix.

Cian Gavin1, Nele Geerts1, Brenton Cavanagh2, Meagan Haynes3, C Patrick Reynolds4,5, Daniela Loessner6,7, Andrew J Ewald3,8, Olga Piskareva1,9,10.   

Abstract

Neuroblastoma is a paediatric malignancy of the developing sympathetic nervous system. About half of the patients have metastatic disease at the time of diagnosis and a survival rate of less than 50%. Our understanding of the cellular processes promoting neuroblastoma metastases will be facilitated by the development of appropriate experimental models. In this study, we aimed to explore the invasion of neuroblastoma cells and organoids from patient-derived xenografts (PDXs) grown embedded in 3D extracellular matrix (ECM) hydrogels by time-lapse microscopy and quantitative image analysis. We found that the ECM composition influenced the growth, viability and local invasion of organoids. The ECM compositions induced distinct cell behaviours, with Matrigel being the preferred substratum for local organoid invasion. Organoid invasion was cell line- and PDX-dependent. We identified six distinct phenotypes in PDX-derived organoids. In contrast, NB cell lines were more phenotypically restricted in their invasion strategies, as organoids isolated from cell line-derived xenografts displayed a broader range of phenotypes compared to clonal cell line clusters. The addition of FBS and bFGF induced more aggressive cell behaviour and a broader range of phenotypes. In contrast, the repression of the prognostic neuroblastoma marker, MYCN, resulted in less aggressive cell behaviour. The combination of PDX organoids, real-time imaging and the novel 3D culture assays developed herein will enable rapid progress in elucidating the molecular mechanisms that control neuroblastoma invasion.

Entities:  

Keywords:  3D invasion assay; extracellular matrix environment (ECM); invasion phenotype; neuroblastoma; organoids

Year:  2021        PMID: 33578855      PMCID: PMC7916632          DOI: 10.3390/cancers13040736

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.575


  71 in total

Review 1.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

2.  Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation.

Authors:  Benjamin Izar; Cailin E Joyce; Stephanie Goff; Nancy L Cho; Parin M Shah; Gaurav Sharma; Jingjing Li; Nageatte Ibrahim; Jason Gold; F Stephen Hodi; Levi A Garraway; Carl D Novina; Monica M Bertagnolli; Charles H Yoon
Journal:  Pigment Cell Melanoma Res       Date:  2016-09-22       Impact factor: 4.693

3.  Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants.

Authors:  Amy E Armstrong; Karina Danner-Koptik; Shannon Golden; Jennifer Schneiderman; Morris Kletzel; Jennifer Reichek; Yasmin Gosiengfiao
Journal:  J Pediatr Hematol Oncol       Date:  2018-01       Impact factor: 1.289

4.  Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice.

Authors:  E Serres; F Debarbieux; F Stanchi; L Maggiorella; D Grall; L Turchi; F Burel-Vandenbos; D Figarella-Branger; T Virolle; G Rougon; E Van Obberghen-Schilling
Journal:  Oncogene       Date:  2013-08-05       Impact factor: 9.867

Review 5.  Preclinical models for neuroblastoma: Advances and challenges.

Authors:  J C Nolan; T Frawley; J Tighe; H Soh; C Curtin; O Piskareva
Journal:  Cancer Lett       Date:  2020-01-18       Impact factor: 8.679

6.  Rac GTPase regulation of 3D invasion in neuroblastomas lacking MYCN amplification.

Authors:  Camilla B Mitchell; Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2016-05-25       Impact factor: 3.405

Review 7.  Neuroblastoma and MYCN.

Authors:  Miller Huang; William A Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

8.  Leader Cells Define Directionality of Trunk, but Not Cranial, Neural Crest Cell Migration.

Authors:  Jo Richardson; Anton Gauert; Luis Briones Montecinos; Lucía Fanlo; Zainalabdeen Mohmammed Alhashem; Rodrigo Assar; Elisa Marti; Alexandre Kabla; Steffen Härtel; Claudia Linker
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

9.  3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT.

Authors:  T J Puls; Xiaohong Tan; Catherine F Whittington; Sherry L Voytik-Harbin
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.

Authors:  Xiangqi Liu; Zhenzhen Zhang; Binbin Zhang; Yijie Zheng; Chao Zheng; Baihui Liu; Shan Zheng; Kuiran Dong; Rui Dong
Journal:  EBioMedicine       Date:  2018-08-10       Impact factor: 8.143

View more
  2 in total

1.  A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor-Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior.

Authors:  Liqun Ning; Jenny Shim; Martin L Tomov; Rui Liu; Riya Mehta; Andrew Mingee; Boeun Hwang; Linqi Jin; Athanasios Mantalaris; Chunhui Xu; Morteza Mahmoudi; Kelly C Goldsmith; Vahid Serpooshan
Journal:  Adv Sci (Weinh)       Date:  2022-05-29       Impact factor: 17.521

Review 2.  Bone Marrow Environment in Metastatic Neuroblastoma.

Authors:  Chiara Brignole; Fabio Pastorino; Patrizia Perri; Loredana Amoroso; Veronica Bensa; Enzo Calarco; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.